The Abdul Latif Jameel Clinic for Machine Learning in Health (J-Clinic) harnesses the power of machine learning for preventative medicine, clinical diagnostics, and drug discovery and development.
What We Do

J-Clinic utilizes a holistic approach that draws on MIT’s strong expertise in cellular and medical biology, computer science, engineering, and the social sciences as it focuses on developing machine learning technologies to revolutionize the prevention, detection, and treatment of disease.

It concentrates on creating and commercializing high-precision, affordable, and scalable machine learning technologies in areas of health care ranging from diagnostics to pharmaceuticals, with


Three Main Areas of Focus:

Creating preventative medicine methods and technologies that can stop non-infectious disease in its tracks
Developing cost-effective diagnostic tests to detect and alleviate health problems
Discovering and developing new pharmaceuticals that can be tailored to
the individual patient

This work focuses on a wide range of conditions that affect millions, from cancer and neurodegenerative disorders such as Alzheimer’s and Parkinson’s to chronic illnesses such as diabetes, kidney disease, and asthma.

J-Clinic leverages MIT’s strong relationship with industry and Boston-area hospitals to test, integrate, and deploy new technologies. It also seeks to advance patentable research that could be commercialized and spun-out through licensing to startups and pharmaceutical companies putting these advances into real-life practice. A key part of the MIT Quest for Intelligence, J-Clinic supports research projects, education, workshops, and other activities at the intersection of machine learning and biology.


Anantha P. Chandrakasan

Chair, J-Clinic

Regina Barzilay

Faculty Lead

Ignacio Fuentes Ribas

Program Director

James J. Collins

Faculty Lead

Phil Sharp

Chair, Advisory Board

Rina Spence

Strategic Lead, External Collaborations

Collaborating on making a better world


J-Clinic is the fourth major collaborative effort between MIT and Community Jameel, the social enterprise organization.

Community Jameel was established in 2003 to continue the Jameel family’s tradition of supporting the community, a tradition started in the 1940s by the late Abdul Latif Jameel, founder of the diversified Abdul Latif Jameel business, who throughout his life helped tens of thousands of disadvantaged people in the fields of healthcare, education and improving livelihoods. Today, Community Jameel is dedicated to supporting social and economic sustainability, across the Middle East and beyond, through a range of initiatives.

Community Jameel has a history of partnering with MIT on initiatives to address the most significant problems facing humankind. Earlier collaborations between MIT and Community Jameel include the Abdul Latif Jameel Poverty Action Lab (J-PAL), established in 2003, which seeks answers to poverty in a changing world; the Abdul Latif Jameel Water and Food Systems Lab (J-WAFS), created in 2014, which addresses food and water scarcity and safety issues as the result of population rises and climate change; and the Abdul Latif Jameel World Education Lab (J-WEL), launched in 2017, which pursues innovative, scalable, and sustainable educational innovation.

Community Jameel and MIT have also collaborated in the Abdul Latif Jameel-Toyota Endowed Scholarship since 1994 and the MIT Enterprise Forum Arab Start-up Competition and Saudi Arabian Start-up Competition.

An initiative of:

  • Twitter - White Circle
  • LinkedIn - White Circle


77 Massachusetts Ave.
Cambridge, MA 02139-4307